Table 2.
National publication volume of lean MASLD.
| Rank | Country | Number of publications | Country | Betweenness centrality |
|---|---|---|---|---|
| 1 | United States | 502 | United States | 0.39 |
| 2 | China | 482 | Spain | 0.14 |
| 3 | Italy | 173 | England | 0.12 |
| 4 | Japan | 153 | Australia | 0.11 |
| 5 | South Korea | 151 | Saudi Arabia | 0.11 |
MASLD = metabolic dysfunction-associated steatotic liver disease.